Marshall Wace’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.1M | Buy |
+362,526
| New | +$1.1M | ﹤0.01% | 1687 |
|
|
2024
Q4 | – | Sell |
-77,351
| Closed | -$142K | – | 2793 |
|
|
2024
Q3 | $142K | Hold |
77,351
| – | – | ﹤0.01% | 2167 |
|
|
2024
Q2 | $161K | Buy |
+77,351
| New | +$161K | ﹤0.01% | 2129 |
|
|
2021
Q4 | – | Sell |
-15,190
| Closed | -$105K | – | 3568 |
|
|
2021
Q3 | $105K | Sell |
15,190
-2,279
| -13% | -$15.8K | ﹤0.01% | 2277 |
|
|
2021
Q2 | $170K | Sell |
17,469
-24,667
| -59% | -$240K | ﹤0.01% | 1965 |
|
|
2021
Q1 | $664K | Buy |
+42,136
| New | +$664K | ﹤0.01% | 1538 |
|